These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8397890)

  • 1. Adverse effects of newer cephalosporins. An update.
    Thompson JW; Jacobs RF
    Drug Saf; 1993 Aug; 9(2):132-42. PubMed ID: 8397890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the third generation cephalosporins.
    Balant L; Dayer P; Auckenthaler R
    Clin Pharmacokinet; 1985; 10(2):101-43. PubMed ID: 3888488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common adverse effects of antibacterial agents on major organ systems.
    Calderwood SB; Moellering RC
    Surg Clin North Am; 1980 Feb; 60(1):65-81. PubMed ID: 6444768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of antibiotics.
    Cunha BA; Ristuccia AM
    Heart Lung; 1984 Sep; 13(5):465-72. PubMed ID: 6236175
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications of antibiotic therapy.
    Ziment I
    Calif Med; 1972 Nov; 117(5):24-48. PubMed ID: 4264289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third generation cephalosporins: safety profiles after 10 years of clinical use.
    Neu HC
    J Clin Pharmacol; 1990 May; 30(5):396-403. PubMed ID: 2189900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to β-lactam antimicrobials.
    Lagacé-Wiens P; Rubinstein E
    Expert Opin Drug Saf; 2012 May; 11(3):381-99. PubMed ID: 22220627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of coxib adverse effects notified in France.
    Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of gold salts].
    Renier JC; Boasson M
    Therapie; 1976; 31(3):365-76. PubMed ID: 136766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse effects of medications. Review of several publications appearing in 1975-6 concerning the adverse effects of medications].
    Lechat P; Lagier G; Rouveix B; Fontagné J
    Therapie; 1977; 32(4):423-57. PubMed ID: 343296
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complications of antibiotic therapy].
    Cah Med; 1971 Dec; 12(17):1527-38. PubMed ID: 5149498
    [No Abstract]   [Full Text] [Related]  

  • 12. A critical review of the literature on carbon disulfide toxicity.
    Beauchamp RO; Bus JS; Popp JA; Boreiko CJ; Goldberg L
    Crit Rev Toxicol; 1983; 11(3):169-278. PubMed ID: 6349939
    [No Abstract]   [Full Text] [Related]  

  • 13. Considerations regarding clinical safety and tolerability of antibiotics in serious and nosocomial infections.
    Smith CR
    Clin Ther; 1981; 4 Suppl A():133-45. PubMed ID: 7034939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 3: cephalosporins.
    Barza M; Miao PV
    Am J Hosp Pharm; 1977 Jun; 34(6):621-9. PubMed ID: 327800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Terminal care. II. Easing of symptoms of cancer patients. 5. Management of adverse effects of antineoplastic agents].
    Kurihara M; Matsukawa M; Yamamoto W; Sato A; Cho T; Akazawa S
    Nihon Naika Gakkai Zasshi; 1996 Dec; 85(12):2032-8. PubMed ID: 9036169
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbon disulfide poisoning: a review.
    Davidson M; Feinleib M
    Am Heart J; 1972 Jan; 83(1):100-14. PubMed ID: 4334674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug side effects in antineoplastic and immunosuppressive cytostatic therapy].
    Hambsch K; Fischer H
    Z Gesamte Inn Med; 1984 Jan; 39(1):7-14. PubMed ID: 6711064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.
    Norrby SR
    Med Toxicol; 1986; 1(1):32-46. PubMed ID: 3537614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tolerance and safety of azlocillin.
    Parry MF
    J Antimicrob Chemother; 1983 May; 11 Suppl B():223-8. PubMed ID: 6619031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse effects of conventional DMARDs and biologic DMARDs].
    Suzuki Y; Saito E; Wakabayashi T; Suwa A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():209-17. PubMed ID: 18074541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.